Literature DB >> 10550299

Chromosomal imbalances in primary lymphomas of the central nervous system.

C H Rickert1, B Dockhorn-Dworniczak, R Simon, W Paulus.   

Abstract

Twenty-two primary central nervous system lymphomas of immunocompetent adults were studied by comparative genomic hybridization. All were high-grade diffuse large B cell lymphomas. Comparative genomic hybridization revealed an average of 5.5 chromosomal changes per tumor, with gains being more common than losses (3.5 vs. 2.0). The most frequent DNA copy number changes were gains on chromosomes 1, 12, 18 (41% each), 7 (23%), and 11 (18%) and losses involving chromosomes 6 (59%), 18, and 20 (18% each). Commonly involved regions were +12q (41%), +18q (36%), +1q (32%), and +7q (23%), as well as -6q (50%), -6p (18%), -17p, and -18p (14% each). High-level gains were found on 7 chromosomes, mainly involving chromosomes 18q (23%), 12q (18%), and 1q (14%). Minimal common regions of over- and underrepresentation were found on +1q25-31, -6q16-21, +7q11.2, +12p11.2-13, +12q12-14, +12q22-24.1, and +18q12.2-21.3. A significant correlation between loss of DNA copy numbers on chromosome 6q and shorter survival could be established (10.2 vs. 22.3 months; P < 0.05). Our findings suggest that chromosomal imbalances of primary central nervous system lymphomas are similar to those of diffuse large B cell lymphomas at other locations and are probably not related to cerebral presentation; however, they may be prognostically relevant.

Entities:  

Mesh:

Year:  1999        PMID: 10550299      PMCID: PMC1866963          DOI: 10.1016/S0002-9440(10)65458-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.

Authors:  C A Werner; H Döhner; S Joos; L H Trümper; M Baudis; T F Barth; G Ott; P Möller; P Lichter; M Bentz
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Expression of oncogenic molecules in primary central nervous system lymphomas in immunocompetent patients.

Authors:  M Nozaki; M Tada; Y Mizugaki; K Takada; K Nagashima; Y Sawamura; H Abe
Journal:  Acta Neuropathol       Date:  1998-05       Impact factor: 17.088

3.  Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract.

Authors:  T F Barth; H Döhner; C A Werner; S Stilgenbauer; M Schlotter; M Pawlita; P Lichter; P Möller; M Bentz
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

Review 4.  The impact of molecular cytogenetics on chronic lymphoid leukaemia.

Authors:  V Brito-Babapulle; J Garcia-Marco; S H Maljaie; L Hiorns; L Coignet; M Conchon; D Catovsky
Journal:  Acta Haematol       Date:  1997       Impact factor: 2.195

5.  Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.

Authors:  J M Cobbers; M Wolter; J Reifenberger; G U Ring; F Jessen; H X An; D Niederacher; E E Schmidt; K Ichimura; F Floeth; L Kirsch; F Borchard; D N Louis; V P Collins; G Reifenberger
Journal:  Brain Pathol       Date:  1998-04       Impact factor: 6.508

6.  Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach.

Authors:  W Y Chan; N Wong; A B Chan; J H Chow; J C Lee
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

7.  The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

Authors:  L M Larocca; D Capello; A Rinelli; S Nori; A Antinori; A Gloghini; A Cingolani; A Migliazza; G Saglio; S Cammilleri-Broet; M Raphael; A Carbone; G Gaidano
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

8.  Chromosomal and gene amplification in diffuse large B-cell lymphoma.

Authors:  P H Rao; J Houldsworth; K Dyomina; N Z Parsa; J C Cigudosa; D C Louie; L Popplewell; K Offit; S C Jhanwar; R S Chaganti
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

10.  Primary central nervous system lymphomas in immunocompetent individuals: histology, Epstein-Barr virus genome, Ki-67 proliferation index, p53 and bcl-2 gene expression.

Authors:  M Krogh-Jensen; P Johansen; F D'Amore
Journal:  Leuk Lymphoma       Date:  1998-06
View more
  8 in total

1.  [Extranodal diffuse large B-cell lymphoma--an organotypic disease?].

Authors:  G Ott; A Rosenwald
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

Review 2.  Introduction of novel agents in the treatment of primary CNS lymphoma.

Authors:  Christian Grommes; Lakshmi Nayak; Han W Tun; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

3.  Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases.

Authors:  C H Rickert; R Sträter; P Kaatsch; H Wassmann; H Jürgens; B Dockhorn-Dworniczak; W Paulus
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome.

Authors:  Luis Del Valle; Sahnila Enam; Cesar Lara; Judith Miklossy; Kamel Khalili; Jennifer Gordon
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

5.  Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.

Authors:  Francois M Cady; Brian Patrick O'Neill; Mark E Law; Paul A Decker; David M Kurtz; Caterina Giannini; Alyx B Porter; Paul J Kurtin; Patrick B Johnston; Ahmet Dogan; Ellen D Remstein
Journal:  J Clin Oncol       Date:  2008-07-21       Impact factor: 44.544

6.  Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q.

Authors:  Ronald Boonstra; Alice Koning; Mirjam Mastik; Anke van den Berg; Sibrand Poppema
Journal:  Virchows Arch       Date:  2003-06-12       Impact factor: 4.064

7.  Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5.

Authors:  Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

8.  Clinicopathological features of primary central nervous system diffuse large B cell lymphoma: Experience from a Tertiary Center in North India.

Authors:  Bishan Dass Radotra; Mayur Parkhi; Debajyoti Chatterjee; Budhi Singh Yadav; Nagarjun Rao Ballari; Gaurav Prakash; Sunil Kumar Gupta
Journal:  Surg Neurol Int       Date:  2020-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.